Samsung Biologics
207940.KS
$559.32
Share price
-1.28%
Change (1 day)
-3.82%
Change (1 year)
Categories
Samsung Biologics (207940.KS) - P/B ratio
P/B ratio as of April 2024 : 5.31
According to Samsung Biologics
's latest financial reports the company has a price-to-book ratio of 5.31.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Samsung Biologics - P/B ratio (from 2016 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 5.50 | -14.96% |
| 2022-12-31 | 6.46 | -45.99% |
| 2021-12-31 | 12.0 | 0.73% |
| 2020-12-31 | 11.9 | 80.63% |
| 2019-12-31 | 6.58 | 6.91% |
| 2018-12-31 | 6.15 | 0.01% |
| 2017-12-31 | 6.15 | 151.4% |
| 2016-12-31 | 2.45 |